国际观察｜新一轮关税或为美国经济又添“败笔”

Core Viewpoint - The new round of tariffs imposed by the U.S. government starting October 1 is expected to negatively impact global supply chains and increase living costs for American citizens, despite being framed as a measure for national security and promoting "Made in America" [1][2]. Tariff Expansion - The U.S. government has announced an expansion of tariffs on a range of products, including pharmaceuticals, heavy trucks, kitchen cabinets, soft furniture, and foreign films. Tariffs on all imported brand or patented drugs will reach up to 100%, effective October 1, while tariffs on wood and kitchen cabinets will be 10% and 25%, respectively, effective October 14 [2][3]. - Prior to this announcement, tariffs already covered nearly one-third of U.S. imports, according to the American Progress Policy Institute [2]. Manufacturing "Reshoring" Ineffectiveness - Experts indicate that the reliance on tariffs to drive manufacturing "reshoring" is unlikely to yield results. The pharmaceutical industry, for instance, is hesitant to commit to reshoring due to unclear policies and the complexity of establishing new manufacturing facilities [3][4]. - The lack of clarity regarding exemptions for generic drugs and the status of companies already operating in the U.S. adds to the uncertainty, making it difficult for pharmaceutical companies to plan effectively [3]. Impact on Pharmaceutical Investment - The imposition of tariffs is expected to hinder pharmaceutical companies' investment plans in the U.S., as the costs associated with tariffs could divert funds away from research and development [4]. - Smaller pharmaceutical companies may opt to exit the U.S. market or sell their product lines due to the inability to relocate production domestically, potentially affecting the supply of certain medications [4]. Consumer Cost Burden - The new tariffs are anticipated to exacerbate inflation in the U.S., with industry insiders warning that the cost pressures from tariffs will likely be passed on to consumers [5][6]. - The American Chamber of Commerce previously stated that tariffs on wood and related products do not pose a national security risk and will increase costs for U.S. businesses and residential construction [5]. - The imposition of tariffs on pharmaceuticals is expected to raise costs and disrupt supply chains, ultimately making it harder for patients to access essential medications [5][6].